Table 1 Summary of model performance metrics

From: Cerebral perfusion imaging predicts levodopa-induced dyskinesia in Parkinsonian rat model

Modality

ACC

AUC

SEN

SPE

PPV

NPV

T2

70.00

60.27

92.86

50.00

61.90

88.89

CBF

83.33

88.84

62.49

100

100

76.19

CBV

86.67*

86.16

92.86

81.25

78.79

92.31

FDG

70.00

64.29

64.29

75.00

69.23

70.59

T2, CBF

76,67

80.36

78.57

75.00

73.68

80.00

T2, CBV

83.33

83.93

92.86

75.00

76.47

92.31

T2, FDG

72.33

65.62

71.43

75.00

71.43

75.00

CBF, CBV

86.67*

90.62

100

75.00

77.78

100

CBF, FDG

76.67

82.14

71.43

81.25

76.92

76.47

CBV, FDG

66.67

70.09

64.29

68.75

64.29

68.75

T2, CBF, CBV

83.33

84.82

85.71

81.25

75.00

92.31

T2, CBF, FDG

76.67

77.23

71.43

81.25

76.92

76.47

T2, CBV, FDG

83.33

82.14

85.71

81.25

75.00

92.31

CBF, CBV, FDG

80.00

83.04

78.57

81.25

75.00

84.21

All

83.33

81.70

85.71

81.25

75.00

92.31

  1. Bold font indicates best performance. An asterisk (*) indicates a tie. FDG fluorodeoxyglucose PET, T2 T2-weighted MRI, CBV cerebrovascular volumetry, CBF cerebrovascular flow. All values are in percentages. Predictive power was computed with an observed sample prevalence of 45.16% or 14 out of 30 subjects.